Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative…